Shares of Fevertree Drinks PLC (LON:FEVR - Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 837.47 and traded as low as GBX 834. Fevertree Drinks shares last traded at GBX 844.50, with a volume of 3,462,251 shares changing hands.
Analyst Ratings Changes
Several research firms recently weighed in on FEVR. Jefferies Financial Group boosted their target price on Fevertree Drinks from GBX 1,080 to GBX 1,100 and gave the stock a "buy" rating in a report on Thursday, July 30th. Berenberg Bank reiterated a "hold" rating and set a GBX 780 price target on shares of Fevertree Drinks in a report on Monday, September 14th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Fevertree Drinks has a consensus rating of "Hold" and a consensus target price of GBX 920.
View Our Latest Stock Analysis on Fevertree Drinks
Fevertree Drinks Trading Up 1.0%
The company has a market capitalization of £952.53 million, a price-to-earnings ratio of 45.88, a P/E/G ratio of -4.51 and a beta of 1.14. The company has a 50-day moving average price of GBX 837.47 and a 200-day moving average price of GBX 816.25. The company has a quick ratio of 3.21, a current ratio of 3.16 and a debt-to-equity ratio of 1.89.
Fevertree Drinks (LON:FEVR - Get Free Report) last posted its quarterly earnings data on Thursday, September 10th. The company reported GBX 9.50 EPS for the quarter. Fevertree Drinks had a return on equity of 11.88% and a net margin of 7.29%. Research analysts predict that Fevertree Drinks PLC will post 38.3184173 EPS for the current fiscal year.
Insider Buying and Selling
In other Fevertree Drinks news, insider Domenico De Lorenzo purchased 44,674 shares of the company's stock in a transaction on Friday, September 11th. The shares were bought at an average cost of GBX 780 per share, with a total value of £348,457.20. 13.09% of the stock is currently owned by corporate insiders.
Fevertree Drinks Company Profile
(
Get Free Report)
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fevertree Drinks, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.
While Fevertree Drinks currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.